Royal Bank Of Canada Haemonetics Corp Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Haemonetics Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 928,052 shares of HAE stock, worth $78.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

928,052

Previous 791,697 17.22%

Holding current value

$78.8 Million

Previous $65.5 Million 13.88%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $9.88 Million - $12.5 Million	136,355 Added 17.22%	928,052 $74.6 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $31.4 Million - $37.6 Million	385,900 Added 95.1%	791,697 $65.5 Million
Q1 2024 Nov 05, 2024	SELL	$71.24 - $85.35 $27.5 Million - $32.9 Million	-385,900 Reduced 48.74%	405,797 $34.6 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $16.1 Million - $19.3 Million	225,570 Added 125.16%	405,797 $34.6 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $1.6 Million - $1.84 Million	-19,871 Reduced 9.93%	180,227 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $1.35 Million - $1.53 Million	16,360 Added 8.9%	200,098 $17.9 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $241,549 - $267,276	2,988 Added 1.65%	183,738 $15.6 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $1.94 Million - $2.41 Million	-26,642 Reduced 12.85%	180,750 $15 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $2.41 Million - $2.81 Million	32,574 Added 18.63%	207,392 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $1.61 Million - $2 Million	25,406 Added 17.0%	174,818 $12.9 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $29,611 - $39,714	-601 Reduced 0.4%	149,412 $9.74 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $6.77 Million - $9.78 Million	-154,640 Reduced 50.76%	150,013 $9.49 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $1.32 Million - $1.99 Million	-26,705 Reduced 8.06%	304,653 $16.2 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $82,944 - $101,649	1,440 Added 0.44%	331,358 $23.4 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $17.1 Million - $39.1 Million	329,918 New	329,918 $22 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Haemonetics Corp Transaction History